Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-1
(Form Type)

 

Alzamend Neuro, Inc.
(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

  Security
Type

Security

Class

Title

Fee

Calculation

or Carry

Forward

Rule

 Amount
Registered (1)

Proposed
Maximum
Offering

Price Per

Share

Maximum

Aggregate

Offering

Price

Fee

Rate

 Amount of
Registration
Fee		 Carry
Forward
Form
Type		 Carry
Forward
File
Number		 Carry
Forward
Initial
effective
date		 Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities
 

Fees to Be

Paid

 Equity Common Stock Rule 457(c) 125,000,000 (2) $0.5826 (3) $72,825,000 (3) $0.00014760 $10,748.97 - - - -
                         

Fees

Previously

Paid

 - - - - - - - - - - - -
 
Carry Forward Securities
                         

Carry

Forward

Securities

 -  - - - - - - - - - - -
                   
  Total Offering Amounts   $72,825,000 (3)   $10,748.97        
                   
  Total Fees Previously Paid       $0        
                   
  Total Fee Offsets       $0        
                   
  Net Fee Due       $10,748.97        

 

(1)Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of common stock that become issuable pursuant to that certain purchase agreement by and between Alzamend Neuro, Inc. and Orchid Finance LLC dated as of May 8, 2024 (the “Purchase Agreement”), as amended by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of the common stock, as applicable.

 

(2)Represents 105,000,000 shares of the Company’s common stock issuable upon the conversion of the Series A Convertible Preferred Stock of the Company and 20,000,000 shares of the Company’s common stock issuable upon the exercise of the warrants to be sold by the Company to the selling stockholder pursuant to the Purchase Agreement.

 

(3)Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the common stock, as reported on The Nasdaq Capital Market on May 29, 2024, which date is within five business days prior to the filing of this registration statement.